Watch Ticker

Rezolute, Inc. Common Stock (NV)

Go to Rezolute, Inc. Common Stock (NV) Website

$5.84

-0.06 (-0.93%)

Live

Previous Close

$5.9

Day Range

$5.79 - $5.97

Previous Day Range

$5.75 - $6.09

Market Cap

$510.7 million USD

Day Vol.

404099

Previous Day Vol.

538405

Currency

USD

Primary Exchange

Nasdaq

Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Rezolute, Inc. - Rezolute Announces Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement

Additional $6.7M in funding resulting in approximately $67M in gross proceeds Additional $6.7M in funding resulting in approximately $67M in gross proceeds

Related tickers: RZLT.

Read Full Article

Rezolute, Inc. - Rezolute Announces Closing of Public Offering with Approximately $60M in Gross Proceeds

NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage biopharmaceutical company committed to developing novel, transformative therapies for serious rare diseases, today announced the closing of its underwritten public offering of 11,250,000 shares of its common stock at a price to the public of $4.00 per share and, to certain investors in lieu of common stock, pre-funded warrants to purchase 3,750,000 shares of its common stock at a price to the public of $3.999 per pre-funded warrant, in each case, before underwriting discounts and commissions. All of the shares and warrants in the public offering were sold by the Company.

Related tickers: RZLT.

Read Full Article

Trending Tickers

Please sign in to view